Optimizing gene delivery vectors for the treatment of heart disease

被引:4
作者
Gray, Steven J. [1 ]
Samulski, R. Jude [1 ]
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
关键词
AAV; Ad; adenovirus; adeno-associated virus; gene therapy; heart; lentivirus; myocardium; plasmid;
D O I
10.1517/14712598.8.7.911
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Cardiac gene therapy is approaching reality, with clinical trials entering Phase II/III. Even so, challenges exist to improve the efficacy of even the most successful therapies. Objective: The merits of different gene therapy vectors are weighed to assess the current feasibility of each in specific cardiac applications. Major obstacles are discussed, along with recent advances in vector development to overcome or circumvent those difficulties. Methods: This review focuses primarily on gene delivery via naked DNA, adenovirus, lentivirus, and adeno-associated virus (AAV) vectors. Conclusion: Gene therapy via adenovirus and AAV vectors has developed into a promising option for the treatment of heart disease. The merits of gene therapy compared with emerging stem cell and microRNA-based treatments are discussed.
引用
收藏
页码:911 / 922
页数:12
相关论文
共 50 条
[41]   Viruses as gene delivery vectors: Application to gene function, target validation, and assay development [J].
Michael T Lotze ;
Thomas A Kost .
Cancer Gene Therapy, 2002, 9 :692-699
[42]   Development of lentiviral vectors for antiangiogenic gene delivery [J].
Toshiaki Shichinohe ;
Bernard H Bochner ;
Kazuo Mizutani ;
Miyako Nishida ;
Susan Hegerich-Gilliam ;
Luigi Naldini ;
Noriyuki Kasahara .
Cancer Gene Therapy, 2001, 8 :879-889
[43]   Peptide-Based Vectors for Gene Delivery [J].
Yang, Juan ;
Luo, Guo-Feng .
CHEMISTRY-SWITZERLAND, 2023, 5 (03) :1696-1718
[44]   Intracellular trafficking of hybrid gene delivery vectors [J].
Keswani, Rahul K. ;
Lazebnik, Mihael ;
Pack, Daniel W. .
JOURNAL OF CONTROLLED RELEASE, 2015, 207 :120-130
[45]   Development of lentiviral vectors for antiangiogenic gene delivery [J].
Shichinohe, T ;
Bochner, BH ;
Mizutani, K ;
Nishida, M ;
Hegerich-Gilliam, S ;
Naldini, L ;
Kasahara, N .
CANCER GENE THERAPY, 2001, 8 (11) :879-889
[46]   Utilizing adenovirus vectors for gene delivery in cancer [J].
Kasala, Dayananda ;
Choi, Joung-Woo ;
Kim, Sung Wan ;
Yun, Chae-Ok .
EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (03) :379-392
[47]   Self-amplifying vectors for gene delivery [J].
Herweijer, H ;
Wolff, JA .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (01) :5-16
[48]   Ocular gene delivery using lentiviral vectors [J].
K S Balaggan ;
R R Ali .
Gene Therapy, 2012, 19 :145-153
[49]   Nanoparticle-Based Vectors for Gene Delivery [J].
S. Patnaik ;
S. K. Tripathi ;
R. Goyal ;
R. P. Gandhi ;
P. Kumar ;
K. C. Gupta .
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2012, 82 (Suppl 1) :59-81
[50]   Gene Delivery to Human Limbal Stem Cells Using Viral Vectors [J].
Song, Liujiang ;
Song, Zhenwei ;
Fry, Nathaniel J. ;
Conatser, Laura ;
Llanga, Telmo ;
Mei, Hua ;
Kafri, Tal ;
Hirsch, Matthew L. .
HUMAN GENE THERAPY, 2019, 30 (11) :1336-1348